Konkamin has established a c v d, in addition to life style, he will need anti plate litherapy, high intensity statin and possible non staten adjuncts. No prevention series is complete without a super deep dive into the greasy world of lipids. And we'll get to that with doctor nechancha and doctor anne marie navarre, our colleagues at duke medical centre.
Play episode from 47:30
chevron_right
Transcript
chevron_right
Transcript
Episode notes
This is the first episode in an important series on cardiovascular prevention. It’s no secret that cardiovascular disease is the #1 killer worldwide; the total impact on humanity is just staggering. A focus on preventing CVD is an impetus for every cardionerd. In this episode Dan, Amit, Carine, and Heather discuss an illustrative case discussion and review the Cardionerds 2+4 paradigm of cardiovascular prevention: 2 fundamental principles of management + 4 steps in risk stratification.
The Cardionerds CV prevention series will include in-depth deep dives on so many topics related to prevention starting with this case discussion. Stay tuned for upcoming episodes on the ABCs of prevention, obesity, hypertension, diabetes mellitus and anti-diabetes agents, personalized risk and genetic risk assessments, hyperlipidemia, women’s cardiovascular prevention, coronary calcium scoring and so much more!
We are truly honored to be producing the Cardionerds CVD Prevention Series in collaboration with the American Society for Preventive Cardiology! The ASPC is an incredible resource for learning, networking, and promoting the ideals of cardiovascular prevention! This series is kicked off by a message from Dr. Amit Khera, President of the American Society for Preventive Cardiology and President of the SouthWest Affiliate of the American Heart Association.
TWO principles of management
Emphasize healthy lifestyle for everyone regardless of risk
Escalate Preventive Measures with ↑ Risk
FOUR steps of risk stratification
Qualitative risk approximation – identify major risk factors and start counseling and education.
Quantitative risk estimation – use a validated model to quantify a patient’s future risk of CVD.
Identify Risk Enhancing Factors – personalize risk if patient is in the gray zones after step 2
